INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
批准号:
3476721
负责人:
DAVID FLEISHER
金额:
$8.21万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-04-01 至 1992-03-31
关键词:
anticonvulsants basolateral membrane binding proteins brush border membrane calcium metabolism calcium transporting ATPase dogs epilepsy gastrointestinal absorption /transport glucose transport homeostasis ion transport laboratory rat membrane channels membrane permeability nutrient interaction pharmacokinetics phenytoin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of the proposed research is to determine the extent
to which coadministered glucose and calcium affect the intestinal
absorption of the orally administered anticonvulsant, phenytoin,
from solution. Phenytoin possesses a narrow therapeutic range
and minor blood level fluctuations can result in dramatic clincial
effects with respect to insufficient activity or effective
overdosage. While the drug is well absorbed from solution, its
poor dissolution and interactions with coadministered substances
in the gastrointestinal (GI) tract can significantly affect its
absorption. Two of these substances (glucose and calcium) apear
to affect interactions at the intestinal membrane from phenytoin
solution. Several reports in the literature and preliminary data
obtained for this proposal indicate that these interactions are
other than effects on solubility.
Phenytoin's long-range side effects include changes in glucose and
calcium homeostasis. Its mechanism of action in excitable cells
appears to involve the drug's binding to membrane protein
channels controlling cellular ion transport (specifically sodium and
calcium). This binding is enhanced in depolarized cells including
those in epileptic foci.
The existence of similar membrane proteins involved in nutrient-
ion cotransport in the leaky epithelia of the small intestine and
ion transport in the tight epithelia of the large intestine suggests
phenytoin binding in the GI tract. The extent of this binding will
be affected by nutrient and ion transport-induced depolarization
of enterocytes. Thus the presentation in the intestinal lumen of
certain coadministered nutrients and ions are suspected of
altering phenytoin's binding to these intestinal transport proteins
resulting in drug absorption effects through a parallel pathway.
Isolation of this phenomenon will be done experimentally through
rat intestinal perfusion studies since this degree of isolation could
most directly link the interaction to clinical significance.
However, more isolated in vitro studies including intestinal ring
uptake, voltage clamping, and possbily brush-border and inside-out
basolateral membrane vesicles as well as isolated cell suspensions
may be required to uncouple those ion trnasport processes
effecting phenytoin membrane transport. In vivo dog experiments
will be used to separate solubility effects from solution-
membrane interactions.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Phenytoin interaction with enteral feedings administered through nasogastric tubes.
苯妥英与通过鼻胃管进行肠内喂养的相互作用。
DOI:
10.1177/0148607190014005513
发表时间:
1990
期刊:
JPEN. Journal of parenteral and enteral nutrition
影响因子:
--
作者:
[Fleisher,D, Sheth,N, Kou,JH]
通讯作者:
Kou,JH
Intestinal water and solute absorption studies: comparison of in situ perfusion with chronic isolated loops in rats.
肠道水和溶质吸收研究:大鼠体内原位灌注与慢性隔离环的比较。
DOI:
10.1023/a:1015848815616
发表时间:
1992
期刊:
Pharmaceutical research
影响因子:
3.7
作者:
[Lu,HH, Thomas,JD, Tukker,JJ, Fleisher,D]
通讯作者:
Fleisher,D
Colonic absorption of antiepileptic agents.
抗癫痫药的结肠吸收。
DOI:
10.1111/j.1528-1157.1997.tb01078.x
发表时间:
1997
期刊:
Epilepsia
影响因子:
5.6
作者:
[Stevenson,CM, Kim,J, Fleisher,D]
通讯作者:
Fleisher,D
The intestinal uptake of "enzymatically-stable" peptide drugs in rats as influenced by D-glucose in situ.
大鼠肠道对“酶稳定”肽药物的摄取受原位 D-葡萄糖的影响。
DOI:
10.1016/0024-3205(94)90132-5
发表时间:
1994
期刊:
Life sciences
影响因子:
6.1
作者:
[Hu,Z, Tse,EG, Monkhouse,DC, Oh,CK, Fleisher,D]
通讯作者:
Fleisher,D
CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs.
CCK 拮抗剂预处理可抑制狗的膳食增强药物吸收。
DOI:
10.1016/s0167-0115(96)00128-0
发表时间:
1997
期刊:
Regulatory peptides
影响因子:
--
作者:
[Miles,C, Dickson,P, Rana,K, Lippert,C, Fleisher,D]
通讯作者:
Fleisher,D
INTESTINAL CLEARANCE--MECHANISMS & PLASMA LEVEL EFFECTS
-
批准号:2415237
-
项目类别:
-
资助金额:$9.35万
-
财政年份:1996
-
负责人:DAVID FLEISHER
-
依托单位:
INTESTINAL CLEARANCE--MECHANISMS & PLASMA LEVEL EFFECTS
-
批准号:2701617
-
项目类别:
-
资助金额:$13.92万
-
财政年份:1996
-
负责人:DAVID FLEISHER
-
依托单位:
INTESTINAL CLEARANCE--MECHANISMS & PLASMA LEVEL EFFECTS
-
批准号:2189039
-
项目类别:
-
资助金额:$14.95万
-
财政年份:1996
-
负责人:DAVID FLEISHER
-
依托单位:
INTESTINAL ABSORPTION/METABOLISM OF H2 ANTAGONISTS
-
批准号:2189038
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1995
-
负责人:DAVID FLEISHER
-
依托单位:
INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
-
批准号:3476717
-
项目类别:
-
资助金额:$8.56万
-
财政年份:1987
-
负责人:DAVID FLEISHER
-
依托单位:
INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
-
批准号:3476718
-
项目类别:
-
资助金额:$8.72万
-
财政年份:1987
-
负责人:DAVID FLEISHER
-
依托单位:
INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
-
批准号:3476719
-
项目类别:
-
资助金额:$8.44万
-
财政年份:1987
-
负责人:DAVID FLEISHER
-
依托单位:
INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
-
批准号:3476720
-
项目类别:
-
资助金额:$7.72万
-
财政年份:1987
-
负责人:DAVID FLEISHER
-
依托单位:
海外基金